MACKENZIE FINANCIAL CORP
Position in BHC — Bausch Health Companies Inc.
CIK 919859
TORONTO ONTARIO, A6
Position in BHC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,802,279
+$72,168 QoQ
Shares Held
365,574
+14.1% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Derivatives in BHC
reported options exposure · as of Sep 30, 2020CallValue
$1,708,545
CallShares
109,945
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $92,574,463 across 16 Drug Manufacturers - Specialty & Generic names. BHC ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,685 | $29,609,949 | |
| 2 | ZTS |
Zoetis Inc.
|
268,075 | $19,263,869 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,367,493 | $9,967,145 | |
| 4 | VTRS |
Viatris Inc
|
572,287 | $9,087,917 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
15,849 | $8,587,463 | |
| 6 | CRON |
Cronos Group Inc.
|
1,597,039 | $4,439,768 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
347,299 | $3,472,990 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
91,604 | $3,103,543 |
All Filings in BHC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,802,279 | 365,574 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,730,111 | 320,391 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,160,859 | 310,915 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,269,940 | 196,890 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,413,871 | 212,293 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,310,925 | 202,616 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,677,334 | 208,106 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $1,644,362 | 201,515 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,601,759 | 2,381,888 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,979,262 | 1,129,054 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $12,532,805 | 1,562,694 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $10,120,727 | 1,231,232 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $9,109,736 | 1,138,717 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $8,852,886 | 1,092,949 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $7,423,041 | 1,182,013 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,467,245 | 1,374,056 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $6,165,073 | 737,449 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $9,279,385 | 406,100 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,882,033 | 357,915 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,041,556 | 216,932 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $6,460,808 | 220,355 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $7,267,380 | 228,966 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,266,804 | 108,981 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,708,545 | 109,945 | Call | Sole | 2020-11-13 | |
| 2020-06-30 | $2,737,903 | 149,694 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,994,212 | 193,175 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||